| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9373be4e32e6dcaaad553440ff1b40da |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-063 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-06 |
| filingDate |
2017-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1a11e87af645fce03b290d17c4a0256
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8be17a4282e4469e08661c499587a48 |
| publicationDate |
2018-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20180112512-A |
| titleOfInvention |
Pharmaceutical composition for animal comprising glutathione reduced |
| abstract |
The present invention relates to an animal pharmaceutical composition comprising a glutathione reduction type as an active ingredient. According to the present invention, it is expected that the effect of the immune enhancement and promotion of the animal, the improvement of the liver function, the alleviation of various stresses (due to vaccination against foot and mouth disease), and the reduction of somatic cell count in the milk of the cow are expected. |
| priorityDate |
2017-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |